Table 1.
Isolation data, lineage and identification of the new isolates in comparison with those of the control strains.
| Isolation data | Identificationd | |||||
|---|---|---|---|---|---|---|
| Straina | Sourceb | Geographic location/year of isolation | Phylogenetic Lineagec | Species PCR/Api20E | Pathovar/clade E | Public Health Hazard |
| New isolates | ||||||
| VV3, VV4, VV5 | Diseased tilapia | Eastern Mediterranean /2016 | ? | +/+ (99.3%) | -/- | + |
| TI417 | Diseased tilapia | Eastern Mediterranean /2019 | ? | +/+ (99.3%) | -/- | + |
| Control strains | ||||||
| YJ016 | Human blood | Asia/1993 | L1 | +/+ (99.3%) | -/- | + |
| CECT 529T | Human blood | USA/1980 | L2 | +/+ (99.3%) | -/- | + |
| CECT 4999 | Diseased eel | Europe/1999 | L2/clade E | +/¿? (54.4%) | +/+ | + |
| CECT 5198 | Diseased eel | Europe/2000 | L2/clade A | +/+ (99.3%) | +/- | - |
| 95-8-161 | Diseased eel | Europe/1995 | L2/clade I | +/+ (99.3%) | +/- | + |
CECT, Spanish Type Culture Collection; T, type strain.
All the new isolates were recovered as pure cultures from internal organs of moribund tilapia. VV3 was isolated from farm A, VV4 and VV5 from farm B and TI417 from farm C.
Phylogenetic lineage determined by Roig et al [11]. L1 includes biotype 1 strains, L2 biotypes 1 and 2 strains and L3 biotype 3 strains. L2-Clade E includes all the zoonotic strains reported to date.
Identification of the isolates was performed at species, pathovar (piscis) and zoonotic clade (clade E) level by PCR targeting vvhA [20], fpcrp (formerly vep07) [21] and seq 61 [21], respectively. Positive (+), negative (-), and doubtful (¿?) identification. The value in parentheses indicates the probability of a good identification according to the API20E profile (5146105, probability 99.3%; 5006005, probability 54.4%).
The public health hazard of the strain was determined by PCR targeting a polymorphism of pilF [22]. Discrimination is based on the amplification of a variable region located within the gene pilF resulting in a 338 bp fragment.